AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...

Dr O'Donovan says psoriasis is not the only skin condition that can be a sign of high cholesterol. Xanthoma - waxy yellow ...

Mindera Health, a leader in precision medicine for dermatological conditions, today announced their participation in ...

The acquisition includes Nimble's investigational candidate, an oral peptide IL23R inhibitor to treat psoriasis.

Biocon Biologics Ltd today announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of YESINTEK®.

Previous studies have found no association between vaccination and MS in adults. To evaluate the association between ...

AbbVie is set to acquire privately held biotech, Nimble Therapeutics, for $200 million to strengthen its immunology pipeline.

The Nimble acquisition, which follows the $1.4 billion buy of Aliada Therapeutics in October, will help AbbVie rebuild and ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

AbbVie ABBV continued its acquisition spree with the announcement of a definitive agreement to acquire private biotech Nimble ...

1 Tapinarof cream 1% was previously approved in 2022 to treat adult patients with mild, moderate, and severe plaque psoriasis ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...